Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rached Alkallas

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2022
Analysis of mRNA Dynamics Using RNA Sequencing DataRached Alkallas, Hamed S Najafabadi
Nature Communications|October 15, 2017
Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's diseaseRached Alkallas, Lisa Fish, Hani Goodarzi, et al.
Nature Communications|November 2, 2018
Publisher Correction: Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's diseaseRached Alkallas, Lisa Fish, Hani Goodarzi, et al.
Communications Biology|August 20, 2022
Pan-cancer analysis of mRNA stability for decoding tumour post-transcriptional programsGabrielle Perron, Pouria Jandaghi, Elham Moslemi, et al.
Nature Cancer|February 5, 2022
Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanomaRached Alkallas, Mathieu Lajoie, Dan Moldoveanu, et al.
Cell Reports|April 6, 2022
Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapyShivshankari Rajkumar, Diana Berry, Kayla A Heney, et al.
Cell Reports|September 28, 2022
A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivationMarek M Drozdz, Ashley S Doane, Rached Alkallas, et al.
Nature Communications|September 24, 2017
Mitochondrial mutations drive prostate cancer aggressionJulia F Hopkins, Veronica Y Sabelnykova, Joachim Weischenfeldt, et al.
BMC Cancer|January 6, 2022
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanomaGeorgia Sofia Karachaliou, Rached Alkallas, Sarah B Carroll, et al.
European Urology|November 6, 2016
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate TumorsEmilie Lalonde, Rached Alkallas, Melvin Lee Kiang Chua, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|July 1, 2022
Analysis of mRNA Dynamics Using RNA Sequencing DataRached Alkallas, Hamed S Najafabadi
Nature Communications|October 15, 2017
Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's diseaseRached Alkallas, Lisa Fish, Hani Goodarzi, et al.
Nature Communications|November 2, 2018
Publisher Correction: Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's diseaseRached Alkallas, Lisa Fish, Hani Goodarzi, et al.
Communications Biology|August 20, 2022
Pan-cancer analysis of mRNA stability for decoding tumour post-transcriptional programsGabrielle Perron, Pouria Jandaghi, Elham Moslemi, et al.
Nature Cancer|February 5, 2022
Multi-omic analysis reveals significantly mutated genes and DDX3X as a sex-specific tumor suppressor in cutaneous melanomaRached Alkallas, Mathieu Lajoie, Dan Moldoveanu, et al.
Cell Reports|April 6, 2022
Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapyShivshankari Rajkumar, Diana Berry, Kayla A Heney, et al.
Cell Reports|September 28, 2022
A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivationMarek M Drozdz, Ashley S Doane, Rached Alkallas, et al.
Nature Communications|September 24, 2017
Mitochondrial mutations drive prostate cancer aggressionJulia F Hopkins, Veronica Y Sabelnykova, Joachim Weischenfeldt, et al.
BMC Cancer|January 6, 2022
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanomaGeorgia Sofia Karachaliou, Rached Alkallas, Sarah B Carroll, et al.
European Urology|November 6, 2016
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate TumorsEmilie Lalonde, Rached Alkallas, Melvin Lee Kiang Chua, et al.
Pageof 2